CSM Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
CSM Advisors's AMGN Position: Q1 2026 in Review
CSM Advisors reduced its Amgen (AMGN) stake by 6.5% in Q1 2026, selling an estimated $24.6K and leaving 985 shares worth $346K. The position accounts for 0.01% of the portfolio, ranked #383.
CSM Advisors first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.96M in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- CSM Advisors held 985 shares of Amgen worth $346K as of Q1 2026.
- CSM Advisors sold 69 Amgen shares in Q1 2026, an estimated $24.6K.
- Amgen made up 0.01% of CSM Advisors's portfolio in Q1 2026, its #383 holding.
- CSM Advisors first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
- CSM Advisors's Amgen position peaked at $3.96M in Q1 2025.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on CSM Advisors's 13F filing for Q1 2026, filed 15 May 2026.